TABLE 1.

PCR primers used in this study

F, forward; R, reverse.

Primer ID	Sequence	Product
A	F, 5′-GCTCCCTGGAGGGACTTATC-3′	2442 bp
	R, 5′-GGGAAACACCATTTCACCTG-3′
B	F, 5′-GCTTCTGGGAGTCCTTTGTG-3′	1298 bp
	R, 5′-ACCATCCCCATTCCTACTCC-3′
C	F, 5′-CCCCTTTTCTCCTCTCAACC-3′	1537 bp
	R, 5′-ATTTTCCCCGTCCAAAGAGT-3′
D	F, 5′-GGGGTCAGGGATATTCTGGT-3′	1565 bp
	R, 5′-AATCTATGCTGAGGCCGAGA-3′
E	F, 5′-CCTGTCATCAAGGGTAGCAGT-3′	1694 bp
	R, 5′-CACAATGCTCAGCTATTCTTGG-3′
F	F, 5′-CAAAGCCCTCTTAGCTTACTGGTT-3′	1829 bp
	R, 5′-CACCAAATATGGTACCCATCAAAG-3′
G	F, 5′-CACCAAATATGGTACCCATCAAAGCCTCATAA-3′	1247 bp
	R, 5′-TGTTCAGGAAGGGCCTAATG-3′
H	F, 5′-CTGCCCTAGGTTGAGCTTTG-3′	1556 bp
	R, 5′GTGGGACATCAGACCGAGTT-3′
I	F, 5′-GCTCATGTCCCTCTCTGCTC-3′	2461 bp
	R, 5′-ACCTCATCTTGGTGCCTCTG-3′
J	F, 5′-ACCCCACCTGACCTTTCTCT-3′	1875 bp
	R, 5′-GGGTGTCTTTGGTGTTTGCT-3′
K	F, 5′-AAGCAAACCCAGCTTTTTGA-3′	1749 bp
	R, 5′-CCCAACCTGTGGTCAGCTAT-3′
L	F, 5′-CCCAGAACTCCATCCTCAAA-3′	895 bp
	R, 5′-CATGTGCAACATGTGACCTTAGGCCTGA-3′
M	F, 5′-GTCCTTCTGACCCCAACTACATAC-3′	957 bp
	R, 5′-TATTTCCTTCACTCGTAGTGGACA-3′
N	F, 5′-AGAAATAGTAGGTGTTCCAGGATAGTGCTG-3′	2017 bp
	R, 5′-AAGTACCTATAGATGCTCCTCTAGCTTTTG-3′
O	F, 5′-ACCTTGCCTTCTCTAGACCAGTTGGCGAGCA-3′	1266 bp
	R, 5′-CACCACCCAGCCTCAGTGAAAGAGTAT-3′
P	F, 5′-TCACTCATCCTGTGCCAAATTGAGACAAAG-3′	1488 bp
	R, 5′-CAAACGACCCCAGCAATTAGCCAAACCA-3′
Q	F, 5′-GCACTTGAAGGTTGTACACAGGACAGAG-3′	1490 bp
	R, 5′-TTTGCAAAGGATATGGAGAGGCATCCATCACCCCATATA-3′
R	F, 5′-CCTCTGTCTGGTGAACTGTGTATT-3′	1894 bp
	R, 5′-AAAATGCAGATTCTGTAGGTCCTC-3′
S	F, 5′-TTCATTTCTTGACCTATGGCTGTA-3′	1890 bp
	R, 5′-CCAGGCAGTATTAGAGATCAGACA-3′
Upstream of TTLL10 to miR-200b	F, 5′-CAAATTAGGGTTCTTAGGGCTGTA-3′	4737 bp
	R, 5′-CGTCATCATTACCAGGCAGTATTA-3′
TTLL10 exon1	F, 5′-TTAGATGTGGAGCCATCTTGGGCT-3′	126 bp
	R, 5′-TGTATTTCCGGGAATGGCAGGAGT-3′
TTLL10 exon3	F, 5′-ACAGAGATGGAAGTGAGGCAC-3′	102 bp
	R, 5′-GCCCTTGAATGGGACAGACAG-3′
ChIP primers for S2	F, 5′-AGAAAGGCCCAGTACAGATGAGTTAGTAAT-3′	120 bp
	R, 5′-CTGATACATGTTCTAACTTGAACTCTTGTGCT-3′
-25-kb site	F, 5′-CCCCTTTTCTCCTCTCAACC-3′	226 bp
	R, 5′-ACCATCCCCATTCCTACTCC-3′
-14-kb site	F, 5′-ACCCCACCTGACCTTTCTCT-3′	141 bp
	R, 5′-ACCTCATCTTGGTGCCTCTG-3′
-10-kb site	F, 5′-CAACTACATACTTGGACTGTTTTTGAAGCTTAGATCACAGA-3′	138 bp
	R, 5′-CATGTGCAACATGTGACCTTAGGCCTGA-3′
Zeb2	F, 5′-TGCCCAACCATGAGTCCTC-3′	121 bp
	R, 5′-GCTTGCAGAATCTCGCCACT-3′
Pkd1	F, 5′-TCTCGGAGCAGAATCAATGCC-3′	102 bp
	R, 5′-CAGAGTTGAGGGACAGTGAGAT-3′
18S	F, 5′-GTAACCCGTTGAACCCCATT-3′	151 bp
	R, 5′-CCATCCAATCGGTAGTAGCG-3′